UBS Cuts National Vision Target to $31 After Quarterly Beat

UBS Group lowered its price target on National Vision Holdings (NASDAQ:EYE) from $34.00 to $31.00 on Friday, while keeping a "buy" rating that implies a potential upside of 77.50% from the stock's current price. The cut landed one day after the optical retailer beat earnings estimates, announced a $100 million buyback, and watched its shares fall 6.0% anyway.

The stock dropped $1.10 in mid-day trading Friday to $17.46 on volume of 758,806 shares, well below its average of 1,907,864. The disconnect between the analyst's implied value and the market's verdict frames the week for the company.

What did the quarter deliver?

On Thursday, November 12, National Vision reported quarterly EPS of $0.30, beating the consensus estimate of $0.17 by $0.13 and nearly tripling the $0.13 earned in the same quarter last year. Revenue rose 4.8% year over year to $510.53 million, though it came in just short of analyst estimates of $512.53 million. The company posted a net margin of 2.47% and return on equity of 6.78%. Management set FY 2026 guidance at $0.950 to $1.030 EPS, while analysts collectively forecast $0.65 EPS for the current fiscal year.

The beat came with a capital return pledge. The Board of Directors approved a share repurchase program on November 12 authorizing up to $100 million in buybacks — as much as 7% of shares outstanding through open market purchases. Buyback authorizations typically signal that leadership views the stock as undervalued.

How does the analyst picture look?

UBS was not alone in recalibrating targets:

• Morgan Stanley cut its target from $22.00 to $21.00 on August 13, rating the stock "equal weight."
• Citigroup trimmed its target from $39.00 to $35.00 on August 13, keeping a "buy" rating.
• Roth Capital restated a "buy" with a $27.00 target on August 13.
• Guggenheim set a $27.00 target on September 11.
• Weiss Ratings upgraded the stock from "hold (c-)" to "hold (c)" on Thursday.
• Barclays maintained "overweight" while cutting its target to $24 from $27.

Seven analysts rate the stock a Buy and four a Hold, giving National Vision an average rating of "Moderate Buy" and an average price target of $29.27, according to MarketBeat.com.

What do the balance sheet and flows show?

The company carries a debt-to-equity ratio of 0.25, a current ratio of 0.59, and a quick ratio of 0.27. Its market capitalization stands at $1.38 billion, with a price-to-earnings ratio of 28.55, a PEG ratio of 1.43, and a beta of 0.96. The fifty-day moving average sits at $17.10; the 200-day figure is $20.97. Shares have traded between a one-year low of $14.75 and a one-year high of $30.02.

Institutional investors moved in during the second quarter. BlackRock bought a new position worth roughly $230,295,000. William Blair Investment Management acquired a stake of about $90,248,000. Wellington Management Group lifted its holdings 39.6%, adding 2,173,887 shares to own 7,669,853 shares valued at $145,804,000. Bank of America Corp DE bought in at about $16,174,000, and Avalon Trust Co at roughly $14,481,000.

Founded in 1990, National Vision operates America's Best Contacts & Eyeglasses, Eyeglass World, and Vista Optical locations, offering exams, prescription eyeglasses, contact lenses, and sunglasses. Management plans 50 to 55 store openings in 2027.

The plain takeaway: earnings beat, money returned, institutions accumulating — yet the market still priced the shares down.